Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease…
$2.43+9.46%
报价 2026-11-06
市值
$41.2M
EV
–
PE (TTM)
–
预期 PE
–
52 周区间距高点 -58.7%
$2.08$5.89
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Biotechnology| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| ATHEAlterity Therapeutics Limited | $41.2M | +9.5% | – | 0% | – | – | – | |
| ATNMActinium Pharmaceuticals, Inc. | $45M | +10.0% | +12800.0% | 101.1% | 4.0x | 0.8x | – | |
| TENXTenax Therapeutics, Inc. | $44.8M | +3.7% | +110.0% | 0% | – | – | – | |
| NMADNOMAD Power Solutions, Inc. | $44.5M | +3.2% | – | 0% | – | – | – | |
| ONCYOncolytics Biotech Inc. | $44.1M | -2.1% | – | 0% | – | – | – | |
| GANXGain Therapeutics, Inc. | $43.9M | +7.2% | – | 0% | – | – | – | |
| BMEABiomea Fusion, Inc. | $41M | -3.5% | +20.0% | 0% | – | – | – | |
| EXOZeXoZymes, Inc. | $40.8M | +7.1% | – | 0% | – | – | – | |
| ALDXAldeyra Therapeutics, Inc. | $38.2M | +2.9% | +336.5% | 0% | – | – | – | |
| 同行中位数 | – | – | +223.3% | 0% | 4.0x | 0.8x | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
报告货币 AUD（非美元）暂无季度数据（首次研究运行后填充）。
研究材料
Filing 摘要
电话会纪要摘要
暂无纪要摘要。